Winifred Werther

756 total citations
27 papers, 568 citations indexed

About

Winifred Werther is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Winifred Werther has authored 27 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 9 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Winifred Werther's work include Multiple Myeloma Research and Treatments (15 papers), Protein Degradation and Inhibitors (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Winifred Werther is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Protein Degradation and Inhibitors (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Winifred Werther collaborates with scholars based in United States, United Kingdom and Switzerland. Winifred Werther's co-authors include Leonard G. Presta, Paula Jardieu, Paul Carter, Tim E. Hotaling, Bosco M. C. Chan, P W Berman, Mark Champe, Ajai Chari, Susan McCabe and Walter T. Linde‐Zwirble and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Winifred Werther

26 papers receiving 539 citations

Peers

Countries citing papers authored by Winifred Werther

Since Specialization

Citations

This map shows the geographic impact of Winifred Werther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winifred Werther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winifred Werther more than expected).

Fields of papers citing papers by Winifred Werther

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Winifred Werther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winifred Werther. The network helps show where Winifred Werther may publish in the future.

Co-authorship network of co-authors of Winifred Werther

This figure shows the co-authorship network connecting the top 25 collaborators of Winifred Werther. A scholar is included among the top collaborators of Winifred Werther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Winifred Werther. Winifred Werther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A temporal and multinational assessment of acute myeloid leukemia (AML) cancer incidence, survival, and disease burden 2024 ·Leukemia & lymphoma ·Laura Anderson, Mariam Girguis, (unknown), Jitesh B. Shewale, Megan Braunlin, Winifred Werther, (unknown), (unknown), (unknown)	4
2	Mortality by a proxy performance status as defined by a claims-based measure for disability status in older patients with newly diagnosed multiple myeloma in the United States 2019 ·Journal of Geriatric Oncology ·Shuling Li, (unknown), Jiannong Liu, Vicki A. Morrison, Sarah Vidito, Winifred Werther, Akeem Yusuf, Saad Z. Usmani	3
3	Identifying Ultra-High Risk Smoldering Multiple Myeloma 2018 ·Blood ·(unknown), Even H Rustad, Venkata Yellapantula, Neha Korde, Sham Mailankody, Nikoletta Lendvai, Alexander M. Lesokhin, Hani Hassoun, Sergio Giralt, Heather Landau, Eric L. Smith, Gunjan L. Shah, Michael Scordo, David J. Chung, Khalid Mezzi, (unknown), Megan Braunlin, Winifred Werther, Ola Landgren, Malin Hultcrantz	1
4	Demographic and Clinical Characteristics of Multiple Myeloma (MM) Patients Treated with Carfilzomib-Based Regimens in a Real World Setting 2017 ·Blood ·(unknown), Winifred Werther, Karim Iskander, Michael L. Gruber, Khalid Mezzi	4
5	Development and Validation of an Algorithm to Identify Patients with Multiple Myeloma Using Administrative Claims Data 2016 ·Frontiers in Oncology ·Nicole Princic, Chris M. Gregory, Tina M. Willson, (unknown), (unknown), Winifred Werther, Gregory Lenhart, Kathleen A. Foley	15
6	Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational, Retrospective, Cohort Study 2016 ·Clinical Lymphoma Myeloma & Leukemia ·Kristin Kistler, Jill Kalman, Gagan Sahni, Brian R. Murphy, Winifred Werther, Kanya Rajangam, Ajai Chari	42
7	Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study 2016 ·BMC Cancer ·Ajai Chari, Khalid Mezzi, Shao Zhu, Winifred Werther, (unknown), Alexander R. Lyon	22
8	Treatment Sequencing Patterns in Medicare-Enrolled Patients with Multiple Myeloma 2016 ·Blood ·Shuling Li, (unknown), Akeem Yusuf, (unknown), Khalid Mezzi, Winifred Werther	1
9	Hospitalization Rates for Newly Diagnosed Multiple Myeloma Patients in the United States Medicare Database 2015 ·Clinical Lymphoma Myeloma & Leukemia ·Akeem Yusuf, (unknown), Winifred Werther, (unknown), (unknown), Kenneth R. Bridges, Yi Peng	0
10	Development of an Algorithm to Identify Patients with Multiple Myeloma Using Administrative Claims Data 2015 ·Blood ·Nicole Princic, Chris M. Gregory, Tina M. Willson, (unknown), (unknown), Winifred Werther, Gregory Lenhart, K. Foley	1
11	Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma 2014 ·Blood ·R. Donald Harvey, Ze Cong, Winifred Werther, (unknown), Sagar Lonial	1
12	Hospitalized cardiovascular events in patients with diabetic macular edema 2012 ·BMC Ophthalmology ·(unknown), Earl Goehring, Winifred Werther, Anne E. Fung, V. Diana, Rajendra S. Apte, Judith K. Jones	22
13	Myocardial Infarction and Cerebrovascular Accident in Patients With Retinal Vein Occlusion 2011 ·Archives of Ophthalmology ·Winifred Werther	53
14	Validation of ICD‐9‐CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients 2011 ·Pharmacoepidemiology and Drug Safety ·Jeffrey R. Curtis, Shih‐Yin Chen, Winifred Werther, Ani John, David A. Johnson	18
15	Myocardial Infarction and Cerebrovascular Accident in Patients With Diabetic Macular Edema 2009 ·Investigative Ophthalmology & Visual Science ·Anne E. Fung, Rajendra S. Apte, (unknown), Earl Goehring, Winifred Werther, Judith K. Jones	1
16	Annual Rates of Arterial Thromboembolic Events in Medicare Neovascular Age-Related Macular Degeneration Patients 2007 ·Ophthalmology ·S. L. Alexander, Walter T. Linde‐Zwirble, Winifred Werther, (unknown), Laura Wilson, (unknown), Namrata Saroj, (unknown), Tsontcho Ianchulev	61
17	A Review of Malignancies Observed during Efalizumab (Raptiva®) Clinical Trials for Plaque Psoriasis 2006 ·Dermatology ·Craig L. Leonardi, Darryl Toth, Jennifer Clay Cather, Richard G. Langley, Winifred Werther, Peter G. Compton, Paul Kwon, Graham Wetherill, François Curtin, Alan Menter	37
18	Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization 2001 ·Journal of Allergy and Clinical Immunology ·Daniel B. Tumas, Betty Chan, Winifred Werther, Terri Wrin, Joann Vennari, (unknown), Robert L. Shields, Paula Jardieu	36
19	Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1 1996 ·The Journal of Immunology ·Winifred Werther, (unknown), (unknown), Susan McCabe, Bosco M. C. Chan, Tim E. Hotaling, Mark Champe, (unknown), Paula Jardieu, P W Berman, Leonard G. Presta	117
20	X‐ray structures of fragments from binding and nonbinding versions of a humanized anti‐CD18 antibody: Structural indications of the key role of V_H residues 59 to 65 1994 ·Proteins Structure Function and Bioinformatics ·Charles Eigenbrot, (unknown), (unknown), Paul Carter, Winifred Werther, (unknown), Geoffrey Fox, (unknown)	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact